Literature DB >> 18622792

Navigated revision knee arthroplasty using a system designed for primary surgery.

Philippe Massin1, Patrick Boyer, Jerome Pernin, Cecile Jeanrot.   

Abstract

While navigation is now recognized as an efficient tool for improving femoro-tibial alignment of primary knee prostheses, its use in revision surgery has not yet been fully evaluated. We describe a procedure based on a bone morphing acquisition performed on the surface of the original implants, followed by a dependant bone cut sequence (tibia first). Using the current system, a preoperative CT-scan measurement of the original femoral component was required. Knee balancing was achieved using spacer blocks, with the trial tibial component and the original femoral component still in place. Preliminary experience from 19 cases, some with severe bone loss requiring reconstruction, is reported. A retrospective comparison to 10 non-navigated revision cases performed concomitantly by the same operating surgeon was carried out. Although there was no significant difference in the number of outliers for the two series, navigation appeared to be a valuable aid in reconstructing both bone extremities, while controlling the level of the joint line. However, definitive validation requires further prospective and comparative investigations in larger series.

Entities:  

Mesh:

Year:  2008        PMID: 18622792     DOI: 10.3109/10929080802230846

Source DB:  PubMed          Journal:  Comput Aided Surg        ISSN: 1092-9088


  2 in total

1.  Novel computer-assisted method for revision arthroplasty of the knee.

Authors:  Hanns-Edgar Hoffart; Harald Dinges; Stefan Kolbeck; Peter Ritschl; Hagen Hommel
Journal:  World J Orthop       Date:  2015-11-18

2.  Computer-assisted navigation is beneficial both in primary and revision surgery with modular rotating-hinge knee arthroplasty.

Authors:  Björn G Ochs; Anna J Schreiner; Peter M de Zwart; Ulrich Stöckle; Christoph Emanuel Gonser
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-09-20       Impact factor: 4.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.